The Alzheimer's Drug Discovery Foundation (ADDF) funds four different categories of research:
The ADDF is interested in novel targets and therapeutic approaches for Alzheimer’s disease, related dementias and cognitive aging. These areas include, but are not limited to:
The ADDF no longer funds anti-amyloid approaches and has limited interest in funding cholinesterase inhibitor programs. For more information on Alzheimer's funding opportunities, please see our Request for Proposals.
The ADDF welcomes potential applicants to direct proposal ideas, questions and comments to:
For more information on the application process or questions regarding an existing application, please contact Hanna Bridges-Curry, Grants Associate.